These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17195384)

  • 41. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The benefit of an invasive approach in thrombolysis-ineligible patients with acute myocardial infarction.
    Svilaas T; Zijlstra F
    Am J Med; 2005 Feb; 118(2):123-5. PubMed ID: 15694894
    [No Abstract]   [Full Text] [Related]  

  • 43. Functional and structural correlates of persistent ST elevation after acute myocardial infarction successfully treated by percutaneous coronary intervention.
    Galiuto L; Barchetta S; Paladini S; Lanza G; Rebuzzi AG; Marzilli M; Crea F
    Heart; 2007 Nov; 93(11):1376-80. PubMed ID: 17309911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The comparison of thrombectomy catheters by primary transcutaneous coronary surgery].
    Movsesiants MIu; Mironkov AB; Abugov SA
    Khirurgiia (Mosk); 2012; (11):58-62. PubMed ID: 23258361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombolytic therapy for acute ST-segment elevation myocardial infarction: should it be given to all patients prior to urgent PCI?
    Conti CR
    Clin Cardiol; 2006 Mar; 29(3):93-5. PubMed ID: 16596829
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy of reperfusion with primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction.
    Ndrepepa G; Schömig A; Kastrati A
    Clin Res Cardiol; 2011 Nov; 100(11):1047-8. PubMed ID: 21822853
    [No Abstract]   [Full Text] [Related]  

  • 47. Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis.
    Grzybowski M; Clements EA; Parsons L; Welch R; Tintinalli AT; Ross MA; Zalenski RJ
    JAMA; 2003 Oct; 290(14):1891-8. PubMed ID: 14532318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of right ventricular ischemia mimicking acute myocardial infarction during coronary angioplasty on the right coronary artery].
    Volponi MC; Raganelli L; Santoboni S; Di Ruzza G; Faticanti G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):193-5. PubMed ID: 17461362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]).
    Gierlotka M; Gasior M; Wilczek K; Hawranek M; Szkodzinski J; Paczek P; Lekston A; Kalarus Z; Zembala M; Polonski L
    Am J Cardiol; 2011 Feb; 107(4):501-8. PubMed ID: 21195380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).
    Antman EM; Anbe DT; Armstrong PW; Bates ER; Green LA; Hand M; Hochman JS; Krumholz HM; Kushner FG; Lamas GA; Mullany CJ; Ornato JP; Pearle DL; Sloan MA; Smith SC; Alpert JS; Anderson JL; Faxon DP; Fuster V; Gibbons RJ; Gregoratos G; Halperin JL; Hiratzka LF; Hunt SA; Jacobs AK;
    Circulation; 2004 Aug; 110(5):588-636. PubMed ID: 15289388
    [No Abstract]   [Full Text] [Related]  

  • 51. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty.
    De Luca G; van't Hof AW; Huber K; Gibson CM; Bellandi F; Arntz HR; Maioli M; Noc M; Zorman S; Zeymer U; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Dudek D;
    Am J Cardiol; 2013 Oct; 112(8):1083-6. PubMed ID: 23910428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.
    Elbarouni B; Cantor WJ; Ducas J; Borgundvaag B; Džavík V; Heffernan M; Buller CE; Langer A; Goodman SG; Yan AT;
    Can J Cardiol; 2014 Dec; 30(12):1555-61. PubMed ID: 25475460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Myocardial infarct with ST segment depression: an absolute contraindication to thrombolytic therapy?].
    Imperadore F; Accardi R; Sheiban I; Vergara G
    G Ital Cardiol; 1999 Jun; 29(6):705-9. PubMed ID: 10396677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Care of acute myocardial infarction in the coronary care units of Piedmont in 2007: results from the 'PRIMA_sweet' region-wide survey.
    Steffenino G; Chinaglia A; Noussan P; Alciati M; Bongioanni S; Rolfo C; Soldà PL; Gnavi R; Picariello R; Orlando A;
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):354-63. PubMed ID: 23941892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
    Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W
    Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Management of ST-elevation myocardial infarction in 2012].
    Cayla G; Silvain J; Ecollan P; Montalescot G; Collet JP
    Ann Cardiol Angeiol (Paris); 2012 Dec; 61(6):447-52. PubMed ID: 23078947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Universal reperfusion therapy can be implemented: lessons from 20 years of management of patients admitted within 6 hours of symptom onset with ST-segment elevation acute myocardial infarction.
    Juliard JM; Golmard JL; Ducrocq G; Himbert D; Aubry P; Garbarz E; Benamer H; Boudvillain O; Tchétché D; Feldman LJ; Burnod A; Greffet A; Lapostolle F; Steg PG
    Arch Cardiovasc Dis; 2009 Apr; 102(4):259-67. PubMed ID: 19427603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the national cardiovascular data registry.
    Wang TY; Peterson ED; Ou FS; Nallamothu BK; Rumsfeld JS; Roe MT
    Am Heart J; 2011 Jan; 161(1):76-83.e1. PubMed ID: 21167337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: a population-based study.
    Ko DT; Atzema CL; Donovan LR; Graham MM; Huynh T; So DY; Wang J; Wijeysundera HC; Tu JV
    Am Heart J; 2011 Apr; 161(4):764-770.e1. PubMed ID: 21473977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.